Literature DB >> 17945337

Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.

Y Yildirim1, S Sehirali, M E Avci, C Yilmaz, K Ertopcu, S Tinar, Y Duman, S Sayhan.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the usefulness of integrated 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (PET/CT) for the detection of para-aortic nodal status and to test whether PET/CT change management strategy in locally advanced cervical cancer (LACC) patients with negative conventional CT findings.
MATERIALS AND METHODS: Sixteen locally advanced (FIGO stage IIB-IVA) cervical squamous cancer patients with negative conventional CT findings were eligible to enter this prospective study. All patients underwent firstly PET/CT scans then extraperitoneal surgical exploration for para-aortic lymphadenectomy. Based on histopathologic confirmation, the accuracy, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the PET/CT for para-aortic lymph node metastasis were estimated.
RESULTS: The median age was 48.7 (range 42-67). The accuracy, sensitivity, specificity, PPV and NPV of the PET/CT were 75%, 50%, 83.3%, 50% and 83.3%, respectively. The treatment was modified in four of sixteen (25%) patients; four patients received EFRT in combination with cisplatin chemotherapy instead of standard pelvic field radiotherapy in combination with cisplatin chemotherapy.
CONCLUSION: Our results, despite our study group is small, suggest that PET/CT is an effective imaging technique in the evaluation of LACC with negative CT findings. It may help planning the management especially selecting radiation field. However, larger controlled studies are needed to recommend PET/CT as an alternative to pre-treatment surgical staging.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945337     DOI: 10.1016/j.ygyno.2007.09.011

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  16 in total

1.  Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy for locally advanced cervical cancer: assessment after 52 consecutive patients.

Authors:  Sébastien Gouy; Catherine Uzan; Stéphanie Scherier; Tristan Gauthier; Enrica Bentivegna; Aminata Kane; Philippe Morice; Frédéric Marchal
Journal:  Surg Endosc       Date:  2013-09-06       Impact factor: 4.584

Review 2.  FDG-PET in gynaecological cancers: recent observations.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11       Impact factor: 9.236

3.  Prognostic importance of lymph node-to-primary tumor standardized uptake value ratio in invasive squamous cell carcinoma of uterine cervix.

Authors:  Hyun Hoon Chung; Gi Jeong Cheon; Jae-Weon Kim; Noh-Hyun Park; Yong Sang Song
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-23       Impact factor: 9.236

4.  Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy.

Authors:  Ozan Cem Guler; Nese Torun; Berna Akkus Yildirim; Cem Onal
Journal:  Br J Radiol       Date:  2018-01-10       Impact factor: 3.039

5.  Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.

Authors:  Mostafa Atri; Zheng Zhang; Farrokh Dehdashti; Susanna I Lee; Shamshad Ali; Helga Marques; Wui-Jin Koh; Kathleen Moore; Lisa Landrum; Jae Weon Kim; Paul DiSilvestro; Eric Eisenhauer; Frederick Schnell; Michael Gold
Journal:  Gynecol Oncol       Date:  2016-07-27       Impact factor: 5.482

6.  Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings.

Authors:  Pedro T Ramirez; Anuja Jhingran; Homer A Macapinlac; Elizabeth D Euscher; Mark F Munsell; Robert L Coleman; Pamela T Soliman; Kathleen M Schmeler; Michael Frumovitz; Lois M Ramondetta
Journal:  Cancer       Date:  2010-11-16       Impact factor: 6.860

7.  Survival outcomes in patients with cervical cancer after inclusion of PET/CT in staging procedures.

Authors:  Henrik Villibald Hansen; Annika Loft; Anne Kiil Berthelsen; Ib Jarle Christensen; Claus Høgdall; Svend Aage Engelholm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-22       Impact factor: 9.236

8.  Paraaortic lymph node metastasis in patients with intra-abdominal malignancies: CT vs PET.

Authors:  Mi-Jung Lee; Mi Jin Yun; Mi-Suk Park; Seung Hwan Cha; Myeong-Jin Kim; Jong Doo Lee; Ki Whang Kim
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

9.  Preoperative PET/CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer.

Authors:  Hyun Hoon Chung; Gi Jeong Cheon; Keon Wook Kang; Jae Weon Kim; Noh-Hyun Park; Yong Sang Song
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04       Impact factor: 9.236

10.  Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma.

Authors:  Erik Mittra; Tarek El-Maghraby; Cesar A Rodriguez; Andrew Quon; I Ross McDougall; Sanjiv S Gambhir; Andrei Iagaru
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.